| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.23T | 1.12T | 1.10T | 1.01T | 910.23B |
| Gross Profit | 342.66B | 323.31B | 307.82B | 281.59B | 256.47B |
| EBITDA | 197.06B | 174.89B | 157.54B | 135.19B | 115.04B |
| Net Income | 98.03B | 92.24B | 75.35B | 61.35B | 58.66B |
Balance Sheet | |||||
| Total Assets | 1.41T | 1.31T | 1.27T | 1.18T | 1.12T |
| Cash, Cash Equivalents and Short-Term Investments | 70.93B | 63.54B | 66.19B | 84.70B | 92.97B |
| Total Debt | 84.55B | 101.29B | 160.35B | 180.63B | 206.82B |
| Total Liabilities | 563.73B | 581.51B | 609.70B | 609.48B | 593.38B |
| Stockholders Equity | 800.16B | 691.77B | 602.52B | 517.09B | 472.90B |
Cash Flow | |||||
| Free Cash Flow | 53.03B | 68.17B | 17.90B | 55.08B | 43.76B |
| Operating Cash Flow | 123.56B | 144.92B | 84.86B | 116.16B | 76.81B |
| Investing Cash Flow | -72.61B | -63.38B | -62.42B | -49.50B | -22.35B |
| Financing Cash Flow | -48.17B | -86.25B | -45.87B | -77.19B | -42.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.87T | 15.91 | 12.05% | 1.50% | 9.27% | 3.50% | |
76 Outperform | ¥10.48T | 26.86 | 32.32% | 0.91% | 23.20% | 93.72% | |
75 Outperform | ¥13.09T | 25.04 | 9.29% | 1.19% | 6.76% | 27.25% | |
75 Outperform | ¥2.98T | 7.80 | 10.06% | 1.21% | 8.13% | 78.79% | |
75 Outperform | ¥633.62B | 8.10 | 9.63% | 2.12% | 1.45% | 4.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥1.44T | 40.59 | 8.39% | 1.49% | 0.83% | -37.84% |